Page last updated: 2024-08-16

troglitazone and osteoprotegerin

troglitazone has been researched along with osteoprotegerin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, JW; Jiang, LS; Jiang, SD; Li, B; Yan, J	1

Other Studies

1 other study(ies) available for troglitazone and osteoprotegerin

Article	Year
Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:12 Topics: Adipogenesis; Anilides; Animals; Bone and Bones; Bone Density; Bone Resorption; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromans; Male; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Osteoprotegerin; PPAR gamma; Random Allocation; RANK Ligand; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Thiazolidinediones; Troglitazone; Wnt Proteins; Wnt Signaling Pathway	2012

Article

Year

Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling.

Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:12

Topics: Adipogenesis; Anilides; Animals; Bone and Bones; Bone Density; Bone Resorption; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chromans; Male; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Osteoprotegerin; PPAR gamma; Random Allocation; RANK Ligand; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Thiazolidinediones; Troglitazone; Wnt Proteins; Wnt Signaling Pathway

2012